SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001387131-22-001918
Filing Date
2022-02-14
Accepted
2022-02-14 16:38:47
Documents
2
Group Members
BKB GROWTH INVESTMENTS, LLCPAUL B. MANNING REVOCABLE TRUST DATED MAY 10, 2000

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP cadl-sc13d_072921.htm SC 13D 68719
2 AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D. ex-1.htm EX-1 5325
  Complete submission text file 0001387131-22-001918.txt   75530
Mailing Address 200 GARRETT STREET SUITE S CHARLOTTESVILLE VA 22902
Business Address
Manning Paul B (Filed by) CIK: 0001494695 (see all company filings)

Type: SC 13D

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Subject) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93359 | Film No.: 22633340
SIC: 2836 Biological Products, (No Diagnostic Substances)